Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study
Vı́ctor Moreno(Ajuntament de L’Hospitalet), Silvia Franceschi(Centro di Riferimento Oncologico), Chris J.L.M. Meijer(Dutch Cancer Society), Núbia Muñóz(Instituto Nacional de Cancerología), Keerti V. Shah(Institut Català d'Oncologia), F. Xavier Bosch(Vall d'Hebron Hospital Universitari), Jan M.M. Walboomers(Unknown), Rolando Herrero(Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud)
Cited by 698
Related Papers
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
SNPStats: a web tool for the analysis of association studies
|Bioinformatics|2006|2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
|The Lancet Infectious Diseases|2007|1.7k